Company Overview - Aomei Medical specializes in the research, production, and sales of medical consumables, disposable medical devices, infection protection products, and home care products [2] - The main products include surgical and wound care, infection protection, advanced dressings, and hygiene care [2] Financial Performance - For Q1 2025, the company reported revenue of 759 million yuan, a year-on-year increase of 1.64%, and a net profit of 86.5 million yuan, reflecting a year-on-year decrease of 7.86% [3] - The gross profit margin for the same period was 30.52% [3] Market Position - As of June 30, the company's stock closed at 8.6 yuan, with a rolling PE ratio of 15.07 times and a total market capitalization of 5.446 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 50.61 times and a median of 37.15 times, Aomei Medical ranks 34th in terms of PE ratio [1] Industry Recognition - The company has received multiple accolades, including being listed among the top 100 private manufacturing enterprises in Hubei in 2022 and recognized for its intelligent manufacturing demonstration factory project in 2023 [2] - Aomei Medical was also awarded the "Outstanding Achievement in Industry-Academia-Research Cooperation Innovation" in 2023 [2]

证券之星消息，2025年6月12日奥美医疗（002950）发布公告称公司于2025年6月12日召开业绩说明会。 具体内容如下： 问：公司股价连续下行，而公司强调注重投资者的长期收益，这是否意味着市场对公司的不认可？公司 如何通过市值管理回报长期投资者？ 答：尊敬的投资者您好！二级市场价格受多种因素影响，维护上市公司股东利益的根本，在于经营好公 司，实现股东长期价值。奥美医疗目前作为海外医用敷料市场龙头，已经构建了深厚的护城河。近年 来，奥美医疗实施国内国外双轮驱动战略，力争未来在国内取得更高的市场份额。同时，公司重视股东 报，公司上市以来，2018-2024年度现金分红累计金额（含拟分红）约10.99亿元，累计分红金额已达公 司募集资金净额的2.29倍。未来，我们会持续重视股东报，为股东创造价值。感谢您的关注！ 问：请说明公司销售产品收入分布及国内、国外占比 答：尊敬的投资者您好！海外市场方面2024年，公司实现境外营业收入275,650.05万元，同比上升 23.43%，占营业收入比重为82.87%。 2024年度，受市场需求复苏及供应链优化等因素影响客户补库存意愿强烈；通过持续提升产品竞争力与 服务水平， ...

奥美医疗分析师会议 调研日期：2025年06月12日 调研行业：医疗器械 参与调研的机构：线上参与"提质增效强信心稳中求进促发展" ——湖北辖区上市公司2025年投资者集体接待日活动暨2024年 度业绩说明会的投资者等 / 机构调研pro小程序 DJvanbao.com 洞见研报 出品 : | Gallia | | | --- | --- | | 11 2 12 200 2 110 | | | 1:给我们 = 影片面临官 = | | | 阿里巴巴佩尼 | | | 钢铁机之题。 8 | 图纸制图: 23 | | 20GB Millio Aller 19 | | | 海双集团 | | | 1 1 80.0 0 | 总机构建 23 | | LOGA: REGH, KETA: 1986 | | | 小麦具日 | | | 的研究次数:8 | 上机构馆:23 | | 定年代的:用者点击:我要的中:主要原因 | | | START SHILL CARD | | | 颜的集团 | | | 例体位次数 4 | 24/40 33 | | FININ EXIAN, BENN, LEWI | | | 極力集团 | | | · 例计以 ...

证券代码：002950 证券简称：奥美医疗 奥美医疗用品股份有限公司 投资者关系活动记录表 编号：2025-002 | 投资者关系活动类别 | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 业绩说明会 | | | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | | 线上参与"提质增效强信心稳中求进促发展"——湖北辖区 | | 参与单位名称及人 | 上市公司2025年投资者集体接待日活动暨2024年度业绩 | | 员姓名 | 说明会的投资者 | | 时间 | 2025年6月12日 14:30-16:50 | | 地点 | 公司通过全景网"投资者关系互动平台" | | | （https://ir.p5w.net）采用网络远程的方式召开业绩说明会 | | 上市公司接待人员姓 | 董事长、总裁崔金海 | | 名 | 董事会秘书郑晓程 1.公司股价连续下行，而公司强调注重投资者的长期 | | | 收益，这是否意味着市场对公司的不认可？公司如何通过 | | 投资者关系活动主 | 市值管理回报长期投资者？ | | 要内容介绍 | ...

Group 1 - The core viewpoint of the news highlights the current stock performance and valuation metrics of Aomei Medical, indicating a low PE ratio compared to the industry average [1] - As of June 9, Aomei Medical's stock closed at 8.89 yuan, with a PE ratio of 15.58, marking a new low in 43 days, and a total market capitalization of 5.63 billion yuan [1] - The medical device industry has an average PE ratio of 50.64, with Aomei Medical ranking 37th among its peers [1] Group 2 - Aomei Medical specializes in the research, production, and sales of medical consumables, disposable medical devices, infection protection products, and home care products [2] - The company has received multiple accolades, including being listed among the top 100 private manufacturing enterprises in Hubei and recognized for its intelligent manufacturing projects [2] - In the latest quarterly report for Q1 2025, Aomei Medical reported a revenue of 759 million yuan, a year-on-year increase of 1.64%, and a net profit of 86.5 million yuan, reflecting a year-on-year decrease of 7.86% [3]

序号股票简称PE(TTM)PE(静)市净率总市值(元)37奥美医疗15.4915.181.5955.98亿行业平均 50.8049.074.67108.36亿行业中值36.7136.842.4850.19亿1天益医疗-1758.71-3012.481.8822.41亿2澳华内 镜-655.90328.975.2569.12亿3诺唯赞-427.65-505.802.3591.52亿4爱朋医疗-397.87302.264.7932.65亿5博晖 创新-335.73532.763.5849.26亿6奥精医疗-136.87-200.611.8125.40亿7硕世生物-136.24-1990.831.2239.85亿 8睿昂基因-101.37-83.231.4413.12亿9康泰医学-88.33-74.633.1558.14亿10中红医疗-72.73-58.010.9250.55亿 11热景生物-55.61-64.074.10122.37亿 资金流向方面，6月3日，奥美医疗主力资金净流出398.02万元，近5日总体呈流出状态，5日共流出 777.00万元。 奥美医疗用品股份有限公司的主营业务是医用耗材及一次性医疗器械、 ...

截至2025年5月30日收盘，奥美医疗（002950）报收于8.69元，较上周的8.69元上涨0.0%。本周，奥美 医疗5月30日盘中最高价报8.79元。5月27日盘中最低价报8.51元。奥美医疗当前最新总市值55.03亿元， 在医疗器械板块市值排名56/126，在两市A股市值排名2655/5146。 本周关注点 机构调研要点 5月23日业绩说明会 问：公司2024业绩不错，股价也处于低位，但是年度分红方案不尽如人意，请公司如何规划年度分红？ 答：公司重视股东回报，最近三个会计年度累计现金分红金额合计91,913,104.51元，累计现金分红金额 高于三个会计年度年均净利润的30%，满足监管对于分红的相关要求。2018-2024年度现金分红（含拟 分红）累计金额约10.99亿元，累计金额已达公司募集资金净额的2.29倍。近两年公司现金分红较以前年 度减少主要系当前公司正处于战略升级期，未来一段时间公司将有资金支出安排投向新兴市场国家业务 国内市场业务、功能性敷料的研发、生产与销售等领域，需确保充足的资金储备。未来，公司会持续重 视股东回报，为股东创造价值。 问：奥美医疗的主业已经做到行业龙头，但护城河不深，公 ...

Group 1 - The core viewpoint of the news highlights the financial performance and market position of Aomei Medical, indicating a decline in stock price and a lower PE ratio compared to the industry average [1][3] - As of May 26, Aomei Medical's stock closed at 8.6 yuan, down 1.04%, with a rolling PE ratio of 15.07 times and a total market capitalization of 5.446 billion yuan [1] - The medical device industry has an average PE ratio of 48.92 times, with Aomei Medical ranking 37th among its peers [1] Group 2 - Aomei Medical specializes in the research, production, and sales of medical consumables, disposable medical devices, infection protection products, and home care products [2] - The company has received multiple accolades, including being listed among the top 100 private manufacturing enterprises in Hubei and recognized for its intelligent manufacturing projects [2] - In the first quarter of 2025, Aomei Medical reported a revenue of 759 million yuan, a year-on-year increase of 1.64%, while net profit decreased by 7.86% to 86.5 million yuan, with a gross profit margin of 30.52% [3]

证券代码：002950 证券简称：奥美医疗 奥美医疗用品股份有限公司 投资者关系活动记录表 编号：2025-001 4.请问奥美在海外市场发展情况如何？ 答:尊敬的投资者您好！目前奥美医疗在海外市场已经实 现较高的市场占有率，2024 年公司实现境外营业收入 275,650.05 万元，同比上升 23.43%，占营业收入比重 为 82.87% 。公司主要产品在美国、欧洲、日韩等发达 国家或地区已经有较高市占率，部分细分产品在美欧均为 市占率第一。目前公司正在大力拓展中东、南美、东南亚、 非洲等新兴市场国家或地区，进一步夯实公司在海外市场 的竞争优势，同时减少对发达国家市场的依赖。感谢您的 关注！ 5.公司本期盈利水平如何? 答:尊敬的投资者您好，根据公司2025年一季度报告，公 司2025年第一季度营业总收入为758,656,819.43元，同 比增长1.64%；净利润为86,652,875.66元，同比下降 7.94%；销售净利率11.42%，在行业内处于领先水平。 | 感谢您的关注！ | | --- | | 6.公司未来的盈利增长点? | | 答:尊敬的投资者您好！尽管目前耗材市场竞争激烈，但 | | 公 ...